Medpace Holdings, Inc.
MEDP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $10 | $9 | $7 | $8 |
| - Cash | $1 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $10 | $9 | $7 | $7 |
| Revenue | $2 | $2 | $1 | $1 |
| % Growth | 11.8% | 29.2% | 27.8% | – |
| Gross Profit | $1 | $1 | $0 | $0 |
| % Margin | 31.1% | 27.8% | 29.6% | 28.7% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 22.6% | 19.3% | 20.6% | 19.2% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 19.2% | 15% | 16.8% | 15.9% |
| EPS Diluted | 12.63 | 8.88 | 7.28 | 4.81 |
| % Growth | 42.2% | 22% | 51.4% | – |
| Operating Cash Flow | $1 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $1 | $0 | $0 | $0 |